The Danger of Loosely Regulated Supplements Blog The Danger of Loosely Regulated Supplements How we can protect ourselves from the $40-50 billion supplement industry amid a shrinking government?
Prevagen Is Going to the Dogs Blog Prevagen Is Going to the Dogs Second Circuit rules FTC/NY case against Prevagen can proceed.
Cancer Center Advertising: When Consumer Education and Regulatory Complaints Aren’t Enough Blog Cancer Center Advertising: When Consumer Education and Regulatory Complaints Aren’t Enough TINA.org strives to educate clinicians about patient testimonials.
Prevagen: The Dismal Facts & Figures that Led to TINA.org’s Objection Blog Prevagen: The Dismal Facts & Figures that Led to TINA.org’s Objection Pending class-action settlement leaves consumers behind.
TINA.org’s Year in Review 2024 Blog TINA.org’s Year in Review 2024 Looking back at our accomplishments.
TINA.org’s Year in Review 2018 Blog TINA.org’s Year in Review 2018 It was another successful year outing deceptive marketing on multiple fronts.
Will Prevagen’s Deceptive Advertising Ever End? Blog Will Prevagen’s Deceptive Advertising Ever End? Eight years after TINA.org alerted regulators, supplement ads continue to convey deceptive and misleading memory improvement claims.
Comment at FDA Public Meeting on Dietary Supplements Blog Comment at FDA Public Meeting on Dietary Supplements Comment made by TINA.org executive director, Bonnie Patten at the FDA’s public meeting on Responsible Innovation in Dietary Supplements held on May 16, 2019. Thank you for the opportunity to…
TINA.org’s Year in Review 2023 Blog TINA.org’s Year in Review 2023 Here’s what we accomplished in 2023 with your help.
TINA.org to Nerium: Take Down Questionable Health and Income Claims Blog TINA.org to Nerium: Take Down Questionable Health and Income Claims Watch for #NeriumTruth social media campaign exposing company’s inappropriate health and income claims.
#NeriumTruth Campaign Summary Blog #NeriumTruth Campaign Summary A recap of TINA.org pressuring Nerium to #GetReal